COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 2662: Articles 26611-26620  | Next

Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-19
Patel, M., Gangemi, A., Marron, R., Chowdhury, J., Yousef, I., Zheng, M., Mills, N., Tragesser, L., Giurintano, J., Gupta, R., Gordon, M., Rali, P., D'Alonzo, G., Fleece, D., Zhao, H., Patlakh, N., Criner, G. J.
10.1101/2020.05.22.20109355 — Posted: 2020-05-26
Assessment of small pulmonary blood vessels in COVID-19 patients using HRCT
Lins, M., Vandevenne, J., Thillai, M., Lavon, B. R., Lanclus, M., Bonte, S., Godon, R., De Backer, J., De Backer, W.
10.1101/2020.05.22.20108084 — Posted: 2020-05-26
COVID-19 in Bangladesh: Measuring differences in individual precautionary behaviors among young adults
Imtiaz, A., Hossain, M. A., Khan, N. M.
10.1101/2020.05.21.20108704 — Posted: 2020-05-26
Currently prescribed drugs in the UK that could up or downregulate ACE2 in COVID-19 disease: A systematic review
Dambha-Miller, H., Albasri, A., Hodgson, S., Wilcox, C. R., Khan, S., Nazrul Islam, N., Little, P., Griffin, S. J.
10.1101/2020.05.19.20106856 — Posted: 2020-05-26
Identification of severity zones for mitigation strategy assessment COVID-19 outbreak in Malaysia
Ahmad, T., Ashaari, A., Awang, S. R., Mamat, S. S., Wan Mohamad, W. M., Ahmad Fuad, A. A., Hassan, N.
10.1101/2020.05.19.20107359 — Posted: 2020-05-26
Expanding Covid-19 Testing: Mathematical Guidelines for the Optimal Sample Pool Size Given Positive Test Rate
Adams, K.
10.1101/2020.05.21.20108522 — Posted: 2020-05-26
Computational Simulation to Assess Patient Safety of Uncompensated COVID-19 Two-patient Ventilator Sharing Using the Pulse Physiology Engine
Webb, J. B., Bray, A., Asare, P. K., Clipp, R. B., Mehta, Y. B., Penupolu, S., Patel, A. A., Poler, S. M.
10.1101/2020.05.19.20107201 — Posted: 2020-05-26
Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia.
Alvarez-Diaz, D. A., Franco-Munoz, C., Laiton-Donato, K., Usme-Ciro, J. A., Franco-Sierra, N. D., Florez, A. C., Gomez Rangel, S., Rodriguez, L. D., Barbosa-Ramirez, J., Ospitia-Baez, E. X., Walteros, D. M., Ospina Martinez, M. L., Mercado-Reyes, M.
10.1101/2020.05.22.20107292 — Posted: 2020-05-26
Chansu Injection Improves the Respiratory Function of Severe COVID-19 Patients
Hu, F., Chen, J., Chen, H., Zhu, J., Wang, C., Ni, H., Cheng, J., Cao, P., Hu, X.
10.1101/2020.05.20.20107607 — Posted: 2020-05-26
Clinical Utility of SARS-CoV-2 Whole Genome Sequencing in Deciphering Source of Infection
Takenouchi, T., Iwasaki, Y. W., Harada, S., Ishizu, H., Uwamino, Y., Uno, S., Osada, A., Hasegawa, N., Murata, M., Takebayashi, T., Fukunaga, K., Saya, H., Kitagawa, Y., Amagai, M., Siomi, H., Kosaki, K.
10.1101/2020.05.21.20107599 — Posted: 2020-05-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).